Bead-based immunoassay for detection of patient-derived SARS-CoV-2 antibodies


This application protocol describes how SARS-CoV-2–specific antibodies can be detected in plasma or serum samples of COVID-19 Convalescents using our biotinylated recombinant SARS-CoV-2 proteins in a bead-based flow cytometric assay. Knowing the humoral response of SARS-CoV-2 convalescent patients is an essential background information to analyze the cellular responses, such as antigen-specific B cell analysis, more in detail.

Protocol

The materials and methods described in this protocol are for detection of patient-derived SARS-CoV-2 antibodies.